Cefzil and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported only by a few people who take Cefzil.

The phase IV clinical study analyzes which people take Cefzil and have Hepatitis c. It is created by eHealthMe based on reports of 1,057 people who have side effects while taking Cefzil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

1,057 people reported to have side effects when taking Cefzil.
Among them, 5 people (0.47%) have Hepatitis c.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,083 Cefzil users for its effectiveness, alternative drugs and more.

What is Hepatitis c?

Hepatitis c is found to be associated with 1,682 drugs and 940 conditions by eHealthMe.

Number of Cefzil and Hepatitis c reports submitted per year:

Time on Cefzil when people have Hepatitis c *:

Gender of people who have Hepatitis c when taking Cefzil *:

female: 20 %
male: 80 %

Age of people who have Hepatitis c when taking Cefzil *:

Common drugs people take besides Cefzil *:

Common side effects people have besides Hepatitis c *:

High Blood Pressure: 3 people, 60.00%
Weight Loss: 2 people, 40.00%
Productive Cough: 2 people, 40.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 40.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 40.00%
Haematochezia (passage of stools containing blood): 2 people, 40.00%
Heart Attack: 2 people, 40.00%
Indigestion: 2 people, 40.00%
Dehydration (dryness resulting from the removal of water): 2 people, 40.00%
Cataract (clouding of the lens inside the eye): 2 people, 40.00%

Common conditions people have *:

* Approximation only. Some reports may have incomplete information.

Do you take Cefzil and have Hepatitis c?

Check whether Hepatitis c is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hepatitis c and when was it recovered:

Hepatitis c in Cefzil

Expand to all the drugs that have ingredients of cefprozil:

Hepatitis c and drugs with ingredients of cefprozil

Alternative drugs to, pros and cons of Cefzil:

Cefzil (1,083 reports)

Hepatitis c treatments and more:

Hepatitis c (129,373 reports)

COVID vaccines that are related to Hepatitis c:

Common drugs associated with Hepatitis c:

All the drugs that are associated with Hepatitis c:

Hepatitis c (1,682 drugs)

Common conditions associated with Hepatitis c:

Hiv infection: 532 reports
Pain: 526 reports
Rheumatoid arthritis: 451 reports
Schizophrenia: 433 reports
Liver transplant: 374 reports

All the conditions that are associated with Hepatitis c:

Hepatitis c (940 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefzil) and Cefzil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.